About Concert pharmaceuticals, inc.
Concert Pharmaceuticals, Inc. is a biopharmaceutical company that is dedicated to creating new possibilities for patients to live their lives. The company was founded in 2006 and has since been committed to developing innovative medicines that address unmet medical needs.
The team at Concert Pharmaceuticals, Inc. is made up of experienced professionals who are passionate about improving the lives of patients. They work tirelessly to develop new treatments for a range of conditions, including central nervous system disorders, autoimmune diseases, and cancer.
One of the key strengths of Concert Pharmaceuticals, Inc. is its focus on de-risking drug development through the use of its proprietary deuterium chemistry platform. This technology allows the company to create novel compounds with improved pharmacokinetic properties and reduced toxicity compared to existing drugs.
Concert Pharmaceuticals, Inc.'s pipeline includes several promising drug candidates that are currently in clinical development. One such candidate is CTP-543, an oral treatment for alopecia areata – an autoimmune disease that causes hair loss on the scalp and other parts of the body.
Another promising candidate is CTP-692, a potential treatment for schizophrenia and other psychiatric disorders. This compound has shown promise in preclinical studies and could represent a significant advance in the treatment of these challenging conditions.
In addition to its internal pipeline, Concert Pharmaceuticals, Inc. also partners with other companies to develop new treatments for patients. For example, it has collaborated with Celgene Corporation on the development of CTP-730 – a potential treatment for inflammatory bowel disease.
Overall, Concert Pharmaceuticals' commitment towards innovation combined with their expertise makes them one-of-a-kind pharmaceutical company dedicated towards improving patient's lives by providing them access to better healthcare facilities through their research & development programs which have resulted into some very promising drug candidates which can potentially cure some life-threatening diseases like alopecia areata & schizophrenia among others.
In conclusion:
Concert Pharmaceuticals' mission statement "Creating new possibilities for PATIENTS TO LIVE THEIR LIVES" truly reflects what they stand by as they continue working towards developing innovative medicines that address unmet medical needs while keeping patient's health as their top priority!